Contrave ER 8-90 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FVWKU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,830
Award facts
- Contract value 100% obligated
- $4,829.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,829.52 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units). This contract represents a firm fixed-price delivery order with no set-aside designation, executed through competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order carries an ultimate completion date of September 19, 2025.
This delivery order is issued as a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor vehicle enables AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs globally. The Contrave ER supply fulfills the Department of Defense's pharmaceutical procurement needs through the Defense Logistics Agency's medical supply chain, supporting healthcare delivery to military personnel and veterans. AmerisourceBergen's status as a major pharmaceutical distributor and federal healthcare solutions provider, combined with its track record of competitively awarded contracts across diverse therapeutic domains, establishes the company's capability to meet federal medical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FVWKU?
SPE2DB25FVWKU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FVWKU worth?
The government has obligated $4,830 on SPE2DB25FVWKU.
Is contract SPE2DB25FVWKU an order under another contract?
Yes. SPE2DB25FVWKU is a delivery order under SPE2DB25D3504, an indefinite delivery contract.
Was contract SPE2DB25FVWKU competed?
The extent of competition for SPE2DB25FVWKU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award